SCHEMBL14510491

SCHEMBL14510491

C[C@@]1(O)[C@H](O)[C@@H](CO)N[C@H]1c1cnn2c(N)ccnc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3888596 0.83 ADORA2A (0.36) —
SCHEMBL13391264 0.76 ADORA2A (0.40) —
SCHEMBL17522713 0.71 ADORA2A (0.35) —
SCHEMBL15740158 0.68 PNP (0.37) —
SCHEMBL5617353 0.64 — —
SCHEMBL3895909 0.64 PNP (0.61) —
SCHEMBL260110 0.63 PNP (0.38) —
SCHEMBL3888177 0.63 PNP (0.38) —
SCHEMBL264914 0.63 PNP (0.38) —
SCHEMBL6228444 0.63 TYK2 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070099942-A1 AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases BIOCRYST PHARMACEUTICALS, INC. (US) 2007-05-03 — — US disclosed
Send feedback